期刊
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
卷 37, 期 4, 页码 336-352出版社
WILEY
DOI: 10.1111/j.1365-2990.2011.01166.x
关键词
amyotrophic lateral sclerosis; axonal transport; mitochondria
资金
- MRC
- Wellcome Trust
- National Institute for Health Research
- Motor Neurone Disease Association
- BBSRC
- NC3Rs
- European Union
- Alzheimer's Research Trust
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G0700628/1] Funding Source: researchfish
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of upper and lower motor neurones leading to muscle weakness and paralysis. Despite recent advances in the genetics of ALS, the mechanisms underlying motor neurone degeneration are not fully understood. Mitochondria are known to be involved in the pathogenesis of ALS, principally through mitochondrial dysfunction, the generation of free radicals, and impaired calcium handling in ALS patients and models of disease. However, recent studies have highlighted the potential importance of altered mitochondrial morphology and defective axonal transport of mitochondria in ALS. Here, we review the evidence for mitochondrial involvement in ALS and discuss potential therapeutic strategies targeting mitochondria.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据